Sarah Cannon Cancer Institute — Nashville, Tennessee

Sarah Cannon Cancer Institute is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.

Sarah Cannon Cancer Institute has participated in 4 clinical trials with 2 currently active.

Therapeutic areas: High-risk Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia (CMML), AML - Acute Myeloid Leukemia.

Sponsors: Crossbow Therapeutics, Inc., Janssen Scientific Affairs, LLC, Takeda.

Sponsor Feasibility Report

Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Cancer Institute?

Sarah Cannon Cancer Institute has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Cancer Institute conducted?

Sarah Cannon Cancer Institute has 4 clinical trials on record, with 2 currently active. Their work covers High-risk Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia (CMML), AML - Acute Myeloid Leukemia.

Is Sarah Cannon Cancer Institute accredited by Crixeo Health?

Sarah Cannon Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sarah Cannon Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.